USPTO trademark

LYRZO

AllowedUSPTOWord markClass 5

"LYRZO" is a word mark owned by AbbVie Inc., filed at the USPTO on October 21, 2025. It has been allowed and covers class 5 (Pharmaceuticals).

Official USPTO record
LYRZO trademark as filed
As filed with the USPTO
Status
Allowed
Since May 26, 2026
Filed
October 21, 2025
Registered
Not yet
Expires
Not recorded
Application no.
99453645
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns LYRZO

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services LYRZO is filed for, grouped by Nice class.

  • Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Noa e-mailed - sou required from applicant
  2. Official gazette publication confirmation e-mailed
  3. Published for opposition
  4. Notification of notice of publication e-mailed
  5. Approved for pub - principal register
  6. Assigned to examiner
  7. Application filing receipt mailed
  8. New application office supplied data entered
  9. New application entered
FAQ

About LYRZO

Who owns the trademark "LYRZO"?

The USPTO trademark "LYRZO" (application 99453645) is owned by AbbVie Inc.

What is the status of "LYRZO"?

Its status at the USPTO is: allowed.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull LYRZO and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2b4a-0581-7438-8f14-eb9e52b95cd4
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2b4a-0581-7438-8f14-eb9e52b95cd4",
  "object": "trademark",
  "mark_text": "LYRZO",
  "status": {
    "primary": "pending",
    "stage": "allowed"
  },
  "office_code": "US",
  "application_number": "99453645",
  "filing_date": "2025-10-21",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "AbbVie Inc.",
      "entity_id": "ent_019ebba6-f00c-713a-b3d0-d4a76c24af73"
    }
  ]
}